For information and resources regarding returning to campus and COVID-19 please visit the university COVID-19 website

Curated Collisions Series

Hindsight is 2020
Health and Life Science Transformations in 2021
and Beyond

December 10, 2020
1 – 4 PM, Online

REGISTER NOW

The Curated Collisions Series kicked off with a 3-hour online event on December 10th, convened by Northeastern University’s Health Sciences Entrepreneurs Program and the Bouvé College of Health Sciences.

Leaders from industry and academia shared their perspectives and approaches to solving the complex problems faced today in health and life sciences, while networking and building collaborations around grand health challenges.

CEOs, SVPs, VPs, Directors, and Managers from collided from pharmaceutical, biotechnology, medical device, healthcare, and higher education organizations such as BridgeBio Pharma, Takeda, MaineHealth, CIC, Vertex, FujiFilm, Harvard i-Lab, Celdara Medical, FBRI, Children’s Hospital Innovation Accelerator, OptimizeRx, Northeastern University, Massachusetts Innovation Network, Tufts Medical Center, Sonde Health, Green D Ventures, BioFurturis, Curated Innovation, Reengineering Cancer Treatment, Lactiga, VocaliD, Saavy Cooperative, Village Plan, Hagan and Co.,  Synesis Law,  MindLeaf Tech, Phimentum, Swifton CFOs, MADASH, RTsafe,  MedTech Strategies, Buchanan, Ingersoll and Rooney, United Health Group – Fusion, Avigo Solutions,  and more!

  • share

Speakers

Evan Falchuk — Speaker at Curated Collisions Northeastern University

Evan Falchuk
Chairman and CEO
Village Plan

Evan's Biography

Evan Falchuk is a business and political entrepreneur focused on creating a better future. He currently serves as the CEO of VillagePlan, a company that helps people navigate the challenge of caring for an aging loved one. From 1999-2013, Evan was Vice-Chairman and President of Best Doctors, Inc. and co-led its growth to 600 employees and serving over 75 million people. Best Doctors is a global healthcare company and the pioneer in getting patients the right diagnosis and treatment through expert medical consultants and novel insurance. It was sold to Teledoc Health for $440 million in 2017.

In 2014, Evan founded the United Independent Party and ran as its candidate for Massachusetts governor. Evan began his career as an attorney and serves on the steering committee of Lawyers Defending American Democracy, a nationwide coalition of lawyers spotlighting abuses of power and calling on the legal profession to act to protect the rule of law.

Jen Horonjeff — Speaker at Curated Collisions Northeastern University

Jen Horonjeff, PhD
Founder and CEO
Savvy Cooperative

Jen's Biography

Jen Horonjeff, PhD, is a patient advocate and the founder & CEO of Savvy Cooperative, the first and only patient-owned co-op that helps innovators connect directly with diverse patients in order to get the insights they need to build better and more inclusive healthcare solutions. Jen was named one of the 50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine, alongside the likes of Elon Musk, Chance the Rapper and Reese Witherspoon for her work at Savvy. She grew up with multiple autoimmune conditions and survived a brain tumor as an adult, and is also a patient-centered outcomes researcher, a human factors engineer, and an FDA advisor. Utilizing her unique perspective, Jen strives to give patients a platform to have their experiences be heard, included, and equitably valued–because the future of healthcare is co-designed with patients.

Stas Gayshan, CIC

Stas Gayshan
General Counsel CIC Health
Managing Director CIC

Stas' Biography

Stas Gayshan is Managing Director at the Cambridge Innovation Center (CIC), the founder of CIC Boston, and General Counsel of CIC Health.

Stas Gayshan joined CIC in early 2014. Previously, Stas was the Founder & CEO of Space with a Soul, a 20,000 square foot co-working space in Boston’s Innovation District. Stas is an entrepreneur and an attorney, and he worked in Democratic political campaigns at various levels prior to starting Space with a Soul. In his political work, Stas focused on the intersection of collaboration, technology and activism.

Stas has been recognized by the Boston Globe as one of the Most Innovative People in Massachusetts Business, and by CJP as one of Boston’s most influential young leaders. He holds leadership positions in several philanthropic and nonprofit organizations active in the Greater Boston area. Stas has a B.A. and J.D. from Boston College.

Satish Tadikonda
Executive Fellow in Entrepreneurship at the Rock Center
Harvard Business School

Satish's Biography

Satish Tadikonda is an entrepreneur in the life sciences and healthcare sectors. His current venture, Avigo, focuses on using healthcare information to optimize clinical trials. Satish is also an Executive Fellow in Entrepreneurship at the Rock Center for Entrepreneurship at Harvard Business School and serves as an Executive Partner of Blue Cloud Ventures, a growth equity fund. Prior to Avigo, Satish was the Founder/CEO of Virtify, Enmed and Tribiosys, all focused on the Life Sciences R&D software and services space.

Satish also serves as a member of the board of directors of several venture-backed companies,  is an active early stage investor, a member of TiE Angels, TBD Angels, and Sky Ventures and co-founder of TiE ScaleUp.  Satish is a mentor for startups at ScaleUp, MassBio’s Activate Program, Mass Challenge and the Harvard iLab.

Satish holds a Doctorate in Electrical and Computer Engineering with a focus on medical imaging.

Event Moderator

Rupal Patel Northeastern University

Rupal Patel
Founder & CEO, VocaliD
Professor, Northeastern University

Rupal's Biography

Rupal is the Founder and CEO of VocaliD, an award-winning voice technology company that provides AI-generated voices with personality. Rupal began her career as a speech clinician where she became fascinated with the potential of using speech technologies for assistive communication which then led to a doctorate in speech science. Her interdisciplinary research applies empirical evidence about speech motor control to develop novel communication technologies. She is currently on leave from Northeastern University where she is a tenured professor in the Bouvé College of Health Sciences and Khoury College of Computer Science and serves on the Board of the Health Sciences Entrepreneurs program.

Rupal was named one of The Top 11 Visionaries in Voice 2019 by Voicebot.ai and Fast Company’s 100 Most Creative People in Business and has been featured on TED, NPR, and in major international news and technology publications.

Agenda

The format will consisted of 4 plenary talks to get us started followed by 3 parallel track breakout sessions at which attendees had an opportunity to network with operators and thought leaders from industry, business, medical, and academic spheres of influence around broad topics related to the state of health and intersections with life science today and the opportunities and challenges for the future. The final session brought attendees back together to share takeaways and next steps.

1:00 – 2:00 PM   Plenary Sessions
2:00 – 3:30 PM  Curated Collisions Breakout Sessions
3:30 – 4:00 PM  Reconvene, Connect and Share

The format will consist of 4 plenary talks to get us started followed by 3 parallel track breakout sessions at which attendees have an opportunity to network with operators and thought leaders from industry, business, medical, and academic spheres of influence around broad topics related to the state of health and intersections with life science today and the opportunities and challenges for the future. The final session will bring attendees back together to share takeaways and next steps.

1:00 – 1:10 Welcome Dean Carmen Sceppa & Rupal Patel
1:10 – 1:35 Featured Plenary Speakers Rupal Patel as Moderator
The reinvention of how we do things Stas Gayshan
The elements that enabled those changes Satish Tadikonda
Impact at a patient level Jen Horonjeff
Impact at a societal level Evan Falchuk
1:35 – 1:55 Group discussion and Q & A Stas Gayshan, Satish Tadikonda, Jen Horonjeff, Evan Falchuk moderated by Rupal Patel
1:55 – 2:00 Break All
2:00 – 2:25 Curated Collisions Session 1 Room 1
Health and life sciences working together to create resilience across the lifespan
Lead Discussant
Rebecca Love
2:00 – 2:25 Curated Collisions Session 1 Room 2
Eliminating global health disparities and Creating health equity
Lead Discussant
Neil Maniar
2:00 – 2:25 Curated Collisions Session 1 Room 3
The impact of technology on the delivery of healthcare in the Changing world
Lead Discussant
Lynn Reede
2:25 – 2:30 Startup Highlights MedSix, Daros, Breegi Scientific
2:30 – 2:55 Curated Collisions Session 2 Room 2
Launching COVID testing in higher education
Lead Discussant
Kim Holloway
Curated Collisions Session 2 Room 3
Bringing a novel drug to market in our Current environment
Lead Discussant
Stu Hemingway – Sponsor BridgeBio
Curated Collisions Session 2 Room 1
Designing healthcare systems for the 22nd Century
Lead Discussant
Evan Falchuk
2:55 – 3:00 Startup Highlights SynCell, Phimentum, Lactiga
3:00 – 3:30 Curated Collisions Session 3 Room 1
Data and analytics: payers, providers and life sciences
Lead Discussant
Satish Tadikonda
Curated Collisions Session 3 Room 2
Novel therapeutics: discovery and development
Lead Discussant
Kim Lewis
Curated Collisions Session 3 Room 3
healthcare and logistics: lessons learned from COVID testing and where to go from here?
Lead Discussant
Stas Gayshan
3:30 – 3:35 Break All
3:35 – 4:00 Reconvene and Share Out, Next Steps All, Moderated by Rupal Patel

TOPICS

  • Drug discovery, development, and delivery and the FDA approval process of how to launch a new drug in our current environment
  • AI and deep learning in drug development
  • Diagnostics and early detectors of disease
  • The impact of technology on the delivery of healthcare in the changing world
  • Data and analytics: payers, providers and life sciences
  • Health science and life science working together to create resilience across the health span
  • Eliminating global health disparities and creating health equity
  • Challenges and opportunities in digital therapeutics

The format will consist of 4 plenary talks to get us started followed by 3 parallel track breakout sessions at which attendees have an opportunity to network with operators and thought leaders from industry, business, medical, and academic spheres of influence around broad topics related to the state of health and intersections with life science today and the opportunities and challenges for the future. The final session will bring attendees back together to share takeaways and next steps.

Plenary Sessions
1:00 – 1:10 PM Opening Remarks
1:10 – 1:20 PM Speaker (Topic)
1:20 – 1:30 PM Speaker (Topic)
1:30 – 1:40 PM Speaker (Topic)
Curated Collisions Sessions
1:40 – 1:50 PM Break – Proceed to breakout rooms
1:50 – 2:20 PM Networking Breakout Session 1 (Topic – 3 parallel sessions, 10 to 15 people in each session)
2:25 – 2:55 PM Networking Breakout Session 2 (Topic – 3 parallel sessions, 10 to 15 people in each session)
3:00 – 3:30 PM Networking Breakout Session 3 (Topic – 3 parallel sessions, 10 to 15 people in each session)
3:30 – 3:50 PM Either a luminary
3:50 – 4:00 PM Wrap-up Gene Tunik

TOPICS

  • Drug discovery, development, and delivery and the FDA approval process of how to launch a new drug in our current environment
  • AI and deep learning in drug development
  • Diagnostics and early detectors of disease
  • The impact of technology on the delivery of healthcare in the changing world
  • Data and analytics: payers, providers and life sciences
  • Health science and life science working together to create resilience across the health span
  • Eliminating global health disparities and creating health equity
  • Challenges and opportunities in digital therapeutics

Sponsors

Bridgebio Pharma, Inc.

Interested in sponsoring this event? Learn more.

Sponsor A

Sponsor B

Sponsor C